# GoodRx Holdings, Inc. (GDRX) · Edgar & Edgarette company card

> GoodRx Holdings (GDRX) grew revenue 0.6% in FY2025 to $797 million, operating margin 11.0% against a 7.7% median for computer processing & data preparation, equity 43.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1809519 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/GDRX) · [JSON](https://www.pops4.com/boards/company/GDRX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $797M |
| Revenue growth, 1 year | 0.6% |
| Revenue growth per year | 1.7% |
| Operating margin | 11.0% (prior year 8.3%) |
| Net margin | 3.8% |
| Operating cash flow | $168M |
| Capital spending | $4M |
| Free cash flow | $164M |
| Cash | $262M |
| Long-term debt | $495M |
| Total assets | $1.4B |
| Total equity | $616M |
| Equity ÷ assets | 43.9% |
| Return on equity | 4.9% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -0.18 (distress zone)
- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: Sound ship · one warning sign · filed earlier statements no longer to be relied on, auditor change in the last 12 months
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $796.9M (FY2025), total debt $495.0M. Experience: revenue up 0.6% on the year, up 1.7% a year over 4 years; operating margin 11.0%, up from 8.3%. Soundness: equity 43.9% of assets, return on equity 4.9%. Credibility: four or more audited years, moderate weight, marked down from reasonable: on 2026-11-02 the company said earlier statements should no longer be relied on (8-K Item 4.02), and no 10-K has been filed since. Range: 80% of past cases like this landed between $695.9M and $892.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $653.4M to $952.5M. A statistical range, not company guidance. Against peers (35 filers, $50M+ revenue, services-computer processing & data preparation): operating margin 11.0% against a 7.7% median; growth 0.6% against 10.2%.

Range logged 2026-11-01, receipt c264339d8d492a12, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 4.02 Earlier statements no longer to be relied on: 1, latest 2026-11-02 ([filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000184/0001809519-26-000184-index.htm))
- Item 4.01 Auditor change: 1, latest 2026-03-18 ([filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000059/0001809519-26-000059-index.htm))
- Item 5.02 Director or officer change: 8, latest 2026-08-05 ([filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/0001809519-26-000153-index.htm))

## Recent filings

- 8-K · filed 2026-11-02 · 4.02 Non-Reliance on Previously Issued Financial Statements · [filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000184/0001809519-26-000184-index.htm)
- 8-K · filed 2026-08-05 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/0001809519-26-000153-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000152/0001809519-26-000152-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000151/0001809519-26-000151-index.htm)
- 8-K · filed 2026-06-18 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/0001809519-26-000133-index.htm)
- 10-Q · filed 2026-05-06 · [filing](https://www.sec.gov/Archives/edgar/data/1809519/000180951926000111/0001809519-26-000111-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001809519.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1809519

## Cite

POPS4, Edgar & Edgarette: GoodRx Holdings, Inc. (GDRX) company card, from the company's own SEC filings, accessed 2026-11-03, https://www.pops4.com/boards/company/GDRX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.